cro.directory
Home
CROss Alliance logo

CROss Alliance

Your fastest track for Phase I studies with deep clinical pharmacology expertise.

Swiss-based CRO with over 500 completed clinical studies, specializing in Phase I research in healthy volunteers and special populations, supported by centralized clinical labs and analytical capabilities. Headquartered in Mendrisio, Switzerland.

Phases

Indications / Therapeutic Areas

Services

Technical specifications & accreditations

About this organization

CROss Alliance is a contract research organization headquartered in Mendrisio, Switzerland, with a dedicated Phase I unit in Arzo. The organization has completed a portfolio of more than 500 clinical studies in both healthy volunteers and patient populations, building deep expertise across multiple therapeutic areas.

Core Capabilities:

  • Phase I studies in healthy volunteers and special populations
  • Drug safety assessment, kinetics, and disposition studies
  • Kinetic-dynamic relationship establishment
  • Therapeutic dose regimen identification
  • Centralized clinical laboratory services
  • Analytical laboratories for drug assay
  • Pharmaceutical formulation technology support

Therapeutic Expertise Areas:

  • Bioequivalence and bioavailability
  • Cardiac safety
  • Central nervous system
  • Dermatology
  • Gastroenterology

Strategic services operate through preferred contracts and long-term collaborations with partner laboratories and pharmaceutical support facilities.

Locations

  • Headquarters

    Mendrisio · Ticino · Switzerland

  • Phase I Unit

    Arzo · Ticino · Switzerland

Similar profiles by shared services, phases, and indications.

Submit a verified review for this organization.

Markdown mirror: /companies/croalliance.md